1
项与 Allogeneic bone marrow-derived mesenchymal stromal cell therapy (Orbsen Therapeutics) 相关的临床试验A Phase 1b, open label, uncontrolled non-randomised single dose study to examine the safety of topically applied bone marrow derived allogeneic mesenchymal stromal cells (REDDSTAR ORBCEL-M) seeded in a collagen scaffold to patients with non-healing neuroischaemic diabetic foot wounds
100 项与 Allogeneic bone marrow-derived mesenchymal stromal cell therapy (Orbsen Therapeutics) 相关的临床结果
100 项与 Allogeneic bone marrow-derived mesenchymal stromal cell therapy (Orbsen Therapeutics) 相关的转化医学
100 项与 Allogeneic bone marrow-derived mesenchymal stromal cell therapy (Orbsen Therapeutics) 相关的专利(医药)
100 项与 Allogeneic bone marrow-derived mesenchymal stromal cell therapy (Orbsen Therapeutics) 相关的药物交易